Literature DB >> 214987

Hepatitis B virus infection and chronic liver disease in Taiwan.

D S Chen, J L Sung.   

Abstract

Three hundred and eighty-five patients mostly with chronic liver diseases and 729 apparently healthy adults were studied for hepatitis B surface antigen (HBsAg) with reversed passive hemagglutination and antibody (anti-HBs) with passive hemagglutination. In healthy adults around 15% was HBsAg positive and in 45% was anti-HBs positive, estimating hepatitis B virus (HBV) infection in nearly two thirds of the population. The infection already occurred before adulthood. The prevalences of HBsAg were invariably over 80% in chronic hepatitis, cirrhosis and hepatocellular carcinoma (hepatoma) indicating an intimate relationship to HBV. On the contrary, the positive rates of anti-HBs in these diseases were far lower than those in healthy people and patients with other diseases, this is similar to the situation in chronic HBsAg carriers. The prevalence of HBsAg in hepatoma patients was unusually high, being 82.7% in contrast to 11.9% in patients with other malignancies. Not only hepatoma patients with cirrhosis but also those without cirrhosis were found to have high prevalence of HBsAg. The fact indicates an even more intimate relationship between hepatoma and HBV.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214987

Source DB:  PubMed          Journal:  Acta Hepatogastroenterol (Stuttg)        ISSN: 0300-970X


  14 in total

1.  Profile of Ding-Shinn Chen.

Authors:  Philip Downey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

2.  Detection of hepatitis B virus DNA in hepatocellular carcinoma.

Authors:  J Y Chen; T J Harrison; C S Lee; D S Chen; A J Zuckerman
Journal:  Br J Exp Pathol       Date:  1986-04

3.  Extrahepatic manifestations of hepatitis B virus infection: Addison's disease and myelofibrosis in a patient with persistent hepatitis B surface antigenemia.

Authors:  F Somlo; G R Berry
Journal:  Can J Infect Dis       Date:  1993-05

4.  Cost without benefit? The introduction of hepatitis B vaccine in Canada.

Authors:  R A Coates; J G Rankin
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

5.  The surgical management of primary carcinoma of the liver.

Authors:  N W Lee; J Wong; G B Ong
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

Review 6.  Immunisation against hepatitis B in Taiwan.

Authors:  I D Gust
Journal:  Gut       Date:  1996       Impact factor: 23.059

Review 7.  Hepatitis B in pregnancy.

Authors:  J A Arevalo
Journal:  West J Med       Date:  1989-06

8.  Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection.

Authors:  T M Ko; L H Tseng; M H Chang; D S Chen; F J Hsieh; S M Chuang; T Y Lee
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

9.  Hepatitis B e antigen and antibody in asymptomatic Chinese with hepatitis B surface antigenemia in Taiwan.

Authors:  J L Sung; D S Chen; M Y Lai; T H Wang; C Y Wang; J Y Yü; C Y Lee
Journal:  Gastroenterol Jpn       Date:  1982

10.  A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program.

Authors:  D S Chen; H M Hsu; C L Bennett; T S Pajeau; B Blumberg; P Y Chang; K Nishioka; A Huang; J L Sung
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.